Page last updated: 2024-11-06

lysergic acid diethylamide and Cephalgia, Vascular

lysergic acid diethylamide has been researched along with Cephalgia, Vascular in 10 studies

Lysergic Acid Diethylamide: Semisynthetic derivative of ergot (Claviceps purpurea). It has complex effects on serotonergic systems including antagonism at some peripheral serotonin receptors, both agonist and antagonist actions at central nervous system serotonin receptors, and possibly effects on serotonin turnover. It is a potent hallucinogen, but the mechanisms of that effect are not well understood.
lysergic acid diethylamide : An ergoline alkaloid arising from formal condensation of lysergic acid with diethylamine.

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-199010 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
FRIEDMAN, AP3
LOSIN, S1
DALESSIO, DJ3
CAMP, WA2
GOODELL, H2
WOLFF, HG2
HALE, AR1
REED, AF1
HARRIS, MC1
ELKIND, AH1
ABBOTT, KH1
CROWTHER, DL1

Other Studies

10 other studies available for lysergic acid diethylamide and Cephalgia, Vascular

ArticleYear
Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
    Archives of neurology, 1961, Volume: 4

    Topics: Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches

1961
Studies on headache. The mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    Archives of neurology, 1961, Volume: 4

    Topics: Headache; Humans; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches

1961
Clinical observations with 1-methyl-lysergic acid butanolamide (UML-491) in vascular headache.
    Angiology, 1960, Volume: 11

    Topics: Headache; Lysergic Acid; Lysergic Acid Diethylamide; Methysergide; Vascular Headaches

1960
Studies in headache: further analysis of the mode of action of UML-491 and its relevance to the nature of vascular headache of the migraine type.
    Transactions of the American Neurological Association, 1961, Volume: 86

    Topics: Headache; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches

1961
Prophylaxis of frequent vascular headache with methysergide.
    The American journal of the medical sciences, 1962, Volume: 243

    Topics: Headache; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches

1962
A new approach to the prophylactic treatment of vascular headache.
    Allergie und Asthma, 1961, Volume: 7

    Topics: Biomedical Research; Headache; Humans; Lysergic Acid Diethylamide; Vascular Headaches

1961
Appraisal of methysergide in treatment of vascular headaches of migraine type.
    JAMA, 1963, Apr-13, Volume: 184

    Topics: Humans; Lysergic Acid Diethylamide; Methysergide; Migraine Disorders; Vascular Headaches

1963
Clinical studies on the treatment of vascular headaches. A further report on Methysergide (Sansert).
    Bulletin of the Los Angeles Neurological Society, 1962, Volume: 27

    Topics: Biomedical Research; Headache; Lysergic Acid Diethylamide; Methysergide; Vascular Headaches

1962
THE PROPHYLACTIC EFFECT OF 1-METHYL-D-LYSERGIC ACID BUTANOLAMIDE (METHYSERGIDE) IN THE TREATMENT OF VASCULAR HEADACHE. A CLINICAL STUDY.
    Medicina experimentalis : International journal of experimental medicine, 1964, Volume: 10

    Topics: Analgesics; Ergot Alkaloids; Facial Neuralgia; Humans; Lysergic Acid; Lysergic Acid Diethylamide; Me

1964
CENTRAL MECHANISMS IN HEADACHE.
    Headache, 1965, Volume: 5

    Topics: Brain; Brain Ischemia; Cerebral Infarction; Drug Therapy; Headache; Humans; Ischemic Attack, Transie

1965